2026. Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β/Smad Signaling. The Review of Diabetic Studies . (Jun. 2026), 62–76. DOI:https://doi.org/10.70082/y1zx3j95.